FORMISANO, LUIGI

FORMISANO, LUIGI  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 62 (tempo di esecuzione: 0.05 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 1.5 Abstract in rivista 2014 Servetto, A.; Raimondo, L.; Formisano, L.; Marciano, R.; Di Mauro, C.; Rosa, R.; D'Amato, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. 1.1 Articolo in rivista 2019 Formisano, L; Lu, Y; Servetto, A; Hanker, Ab; Jansen, Vm; Bauer, Ja; Sudhan, Dr; Guerrero-Zotano, Al; Croessmann, S; Guo, Y; Ericsson, Pg; Lee, Km; Nixon, Mj; Schwarz, Lj; Sanders, Me; Dugger, Tc; Cruz, Mr; Behdad, A; Cristofanilli, M; Bardia, A; O'Shaughnessy, J; Nagy, Rj; Lanman, Rb; Solovieff, N; He, W; Miller, M; Su, F; Shyr, Y; Mayer, Ia; Balko, Jm; Arteaga, Cl.
Activating PIK3CA mutations induce an epidermal growth factor receptor (EGFR)/extracellular signal-regulated Kinase (ERK) paracrine signaling axis in basal-like breast cancer 1.1 Articolo in rivista 2015 Young, Christian D.; Zimmerman, Lisa J.; Hoshino, Daisuke; Formisano, Luigi; Hanker, Ariella B.; Gatza, Michael L.; Morrison, Meghan M.; Moore, Preston D.; Whitwell, Corbin A.; Dave, Bhuvanesh; Stricker, Thomas; Bhola, Neil E.; Silva, Grace O.; Patel, Premal; Brantley-Sieders, Dana M.; Levin, Maren; Horiates, Marina; Palma, Norma A.; Wang, Kai; Stephens, Philip J.; Perou, Charles M.; Weaver, Alissa M.; O'Shaughnessy, Joyce A.; Chang, Jenny C.; Park, Ben Ho; Liebler, Daniel C.; Cook, Rebecca S.; Arteaga, Carlos L.
Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer 1.1 Articolo in rivista 2013 Rosa, Roberta; Damiano, Vincenzo; Nappi, Lucia; Formisano, Luigi; Massari, F.; Scarpa, A.; Martignoni, G.; Bianco, Roberto; Tortora, G.
Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer 1.1 Articolo in rivista 2017 Formisano, Luigi; Stauffer, Kimberly Mae; Young, Christian D; Bhola, Neil E; Guerrero Zotano, Angel L; Jansen, Valerie M; Estrada, Monica M; Hutchinson, Katherine E; Giltnane, Jennifer M; Schwarz, Luis J; Lu, Yao; Balko, Justin M; Deas, Olivier; Cairo, Stefano; Judde, Jean Gabriel; Mayer, Ingrid A; Sanders, Melinda; Dugger, Teresa C; Bianco, Roberto; Stricker, Thomas; Arteaga, Carlos L.
C-Src and EGFR inhibition in molecular cancer therapy: What else can we improve? 1.1 Articolo in rivista 2020 Belli, S.; Esposito, D.; Servetto, A.; Pesapane, A.; Formisano, L.; Bianco, R.
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. 1.1 Articolo in rivista 2018 Schettini, F; De Santo, I; Rea, Cg; De Placido, P; Formisano, L; Giuliano, M; Arpino, G; De Laurentiis, M; Puglisi, F; De Placido, S; Del Mastro, L.
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 1.1 Articolo in rivista 2013 Rosa, R.; Damiano, V.; Formisano, L.; Nappi, L.; Marciano, R.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer. 1.1 Articolo in rivista 2019 Croessmann, S; Formisano, L; Kinch, Ln; Gonzalez-Ericsson, Pi; Sudhan, Dr; Nagy, Rj; Mathew, A; Bernicker, Eh; Cristofanilli, M; He, J; Cutler RE, Jr; Lalani, As; Miller, Va; Lanman, Rb; Grishin, Nv; Arteaga, Cl.
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents 1.1 Articolo in rivista 2020 Ciciola, Paola; Cascetta, Priscilla; Bianco, Cataldo; Formisano, Luigi; Bianco, Roberto
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 1.1 Articolo in rivista 2014 D'Amato, V; Rosa, R; D'Amato, C; Formisano, L; Marciano, R; Nappi, L; Raimondo, L; Di Mauro, C; Servetto, A; Fusciello, C; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 1.1 Articolo in rivista 2014 Formisano, L; Nappi, L; Rosa, R; Marciano, R; D., Amato C; D., Amato V; Damiano, V; Raimondo, L; Iommelli, F; Scorziello, Antonella; Troncone, Giancarlo; Veneziani, BIANCA MARIA; Parsons, Sj; DE PLACIDO, Sabino; Bianco, Roberto
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors 1.1 Articolo in rivista 2018 Guerrero-Zotano, Angel; Stricker, Thomas; Formisano, Luigi; E Hutchinson, Katherine; Stover, Daniel G.; Lee, Kyung-min; J Schwarz, Luis; Giltnane, Jennifer M.; V Estrada, Monica; M Jansen, Valerie; Servetto, Alberto; Gavilá, Joaquín; Alejandro Pérez-Fidalgo, José; Lluch, Ana; Llombart-Cussac, Antonio; Amine Bayar, Mohamed; Michiels, Stefan; Andre, Fabrice; Arnedos, Monica; Guillem, Vicente; RUIZ-SIMON, Amparo
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression. 1.1 Articolo in rivista 2017 Schwarz, Lj; Hutchinson, Ke; Rexer, Bn; Estrada, Mv; Gonzalez Ericsson, Pi; Sanders, Me; Dugger, Tc; Formisano, L; Guerrero-Zotano, A; Red-Brewer, M; Young, Cd; Lantto, J; Pedersen, Mw; Kragh, M; Horak, Id; Arteaga, Cl.
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 1.1 Articolo in rivista 2022 Pisapia, Pasquale; Iaccarino, Antonino; DE LUCA, Caterina; Acanfora, Gennaro; Bellevicine, Claudio; Bianco, Roberto; Daniele, Bruno; Ciampi, Luisa; De Felice, Marco; Fabozzi, Teresa; Formisano, Luigi; Giordano, Pasqualina; Gridelli, Cesare; Pietro Ianniello, Giovanni; Libroia, Annamaria; Maione, Paolo; Nacchio, Mariantonia; Pagni, Fabio; Palmieri, Giovanna; Pepe, Francesco; Russo, Gianluca; Salatiello, Maria; Santaniello, Antonio; Scamarcio, Rachele; Seminati, Davide; Troia, Michele; Troncone, Giancarlo; Vigliar, Elena; Malapelle, Umberto
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 1.1 Articolo in rivista 2016 Raimondo, Lucia; D'Amato, Valentina; Servetto, Alberto; Rosa, Roberta; Marciano, Roberta; Formisano, Luigi; DI MAURO, Concetta; Orsini, Roberta Clara; Cascetta, Priscilla; Ciciola, Paola; DE MAIO, ANA PAULA; di Renzo, Maria Flavia; Cosconati, Sandro; Bruno, Agostino; Randazzo, Antonio; Napolitano, Filomena; Montuori, Nunzia; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies. 1.1 Articolo in rivista 2012 Palmieri, G; Buonerba, C; Federico, P; Formisano, L; Nappi, L; Di Lorenzo, G; Marino, M; Damiano, V.
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial. 1.1 Articolo in rivista 2019 Sudhan, Dr; Schwarz, Lj; Guerrero-Zotano, A; Formisano, L; Nixon, Mj; Croessmann, S; González Ericsson, Pi; Sanders, M; Balko, Jm1; Avogadri-Connors, F; Cutler, Re; Lalani, As; Bryce, R; Auerbach, A; Arteaga, Cl.
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors 1.1 Articolo in rivista 2021 Servetto, A.; Formisano, L.; Arteaga, C. L.
FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer. 1.1 Articolo in rivista 2019 Formisano, L; Drago, Jz; Juric, D; Niemierko, A; Servetto, A; Wander, Sa; Spring, Lm; Vidula, N; Younger, J; Peppercorn, J; Yuen, M; Malvarosa, G; Sgroi, D; Isakoff, Sj; Moy, B; Ellisen, Lw; Iafrate, Aj; Arteaga, Cl; Bardia, A